Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2020-30: Covid 19 Impact and Recovery

Region:Global

Author(s):

Product Code:7639

Download Sample Report download
Buy the Full ReportStarting from $4000
Published on

April 2020

Total pages

300

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $4000

About the Report

About the Report

Major players in the pharmaceutical contract development and manufacturing market are Recipharm AB, Pfizer Inc., Boehringer Ingelheim International GmbH., Aenova Group, Famar, Jubilant Life Sciences Limited, Catalent Pharma Solutions, Chemicals Limited, Dishman Pharmaceuticals and HAUPT Pharma AG.
 
The global pharmaceutical contract development and manufacturing market is expected to decline from USD 99.8 billion in 2019 to USD 93 billion in 2020 at a compound annual growth rate (CAGR) of -7%. The decline is mainly due to the focus on Covid-19 outbreak and its treatment across the globe, and disruption in the supply chain owing to geographical trade barriers affecting the supply of APIs and raw materials for drug manufacturing. Sponsors contracting CMOs are pausing the drug development activities due to Covid19 or restructuring the current drug development plans. The market is then expected to recover and reach USD 128.4 billion in 2023 at a CAGR of 6.5%.
 
The pharmaceutical contract development and manufacturing market consists of sales of pharmaceutical contract development and manufacturing products and related services. Some pharmaceutical companies outsource the manufacturing of products on contracts to focus on the R&D, marketing and branding of their products. The pharmaceutical contract development and manufacturing market consists of manufacturing firms who manufacture drugs and other pharmaceutical products for other pharmaceutical companies on contractual basis.
 
The pharmaceutical contract manufacturing organization market (CMO) market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019.
 
The pharmaceutical contract development and manufacturing market covered in this report is segmented by type into active pharmaceutical ingredient (API) manufacturing, finished dosage formulation (FDF) development & manufacturing and secondary packaging.
 
The companies in the pharmaceutical contract development and manufacturing market are investing towards acquiring and forming alliances with other companies in the market. The pharmaceutical contract development and manufacturing companies are following the trend of merger and acquisition in order to expand their global market reach to meet the client needs, to increase their production capabilities while maintaining cost efficiencies and to get access to latest technology and new services. The high level of merger and acquisition activities are resulting in consolidation of the contract service providers. For instance, according to Zymewire, a Canada based digital sales research assistant, the number of total acquisitions of pharmaceutical contract development and manufacturing companies was 130 for the period from 2015-2017 with 70% of the companies acquiring were operating companies and remaining 30% of company acquisitions were by public equity firms.
 
The pharmaceutical contract development and manufacturing market is restricted by the poor-capacity utilization of manufacturing facilities. The capacity utilization is calculated considering the full potential capacity of the production plant. The poor-capacity utilization of the production plant is caused due to the inefficiency of different sub-processes in the production line which results in low production. The low production output results in low revenue generation for the production unit, affecting the overall pharmaceutical contract development and manufacturing market. For instance, according to an article by the Trade Promotion Council of India (TPCI) most of the pharmaceutical production units in India run at 30-40% of their capacity. Therefore, the under usage of capacity of production plant negatively affects the pharmaceutical contract development and manufacturing market.
 
In 2019, Permira Funds, a European equity firm acquired Cambrex Corporation for USD 2.4 billion. The acquisition is aimed to strengthen and expand the products and services offered by Cambrex Corporation towards the manufacturing of drugs. The Cambrex Corporation is a USA based contract development and manufacturing (CDMO) firm involved with the products and services related to small molecule active pharmaceutical ingredients.
 
The growth of the pharmaceutical contract development and manufacturing market is driven by the increase in the demand for medicines across the globe. The high prevalence of diseases and the need for a longer lifespan increased the demand for medicines pushing the pharmaceutical companies to increase the production of existing drugs and rise the investment in their R&D to promote the development of new drugs. This impels the pharmaceutical companies to collaborate with contract manufacturing organizations (CMOs) as a way to lower operational costs, thus, increasing the demand in pharmaceutical contract development and manufacturing market. For instance, as reported by PutmanMedia, a USA based online media firm, in 2018, 51% of the total New Molecular Entities (NMEs) approved by the US Food and Drug Administration were outsourced to contract manufacturers whereas a total amount of USD 86 billion was given to the contracted services for R&D. The rising need for medicines is thereby boosting the growth of the pharmaceutical contract development and manufacturing market.
 
 

Products

Products

1) By Type: Active Pharmaceutical Ingredient (API) Manufacturing; Finished Dosage Formulation (FDF) Development & Manufacturing; Secondary Packaging


Companies

Recipharm AB; Pfizer Inc.; Boehringer Ingelheim International GmbH.; Aenova Group; Famar; Jubilant Life Sciences Limited,; Catalent Pharma Solutions; Chemicals Limited; Dishman Pharmaceuticals; HAUPT Pharma AG; Kemwell Pvt. Ltd.; Nipro Corp.; NextPharma; Royal DSM N.V; Althea Technologies; Thermo Fisher Scientific Inc.; Lonza Group Ltd; AbbVie Inc.; Consort Medical plc; Almac Group; Siegfried Holding AG; Evonik Industries AG; Vetter Pharma International GMBH

Table of Contents

Table of Contents

1. Executive Summary

2. Pharmaceutical Contract Development And Manufacturing Market Characteristics

3. Pharmaceutical Contract Development And Manufacturing Market Size And Growth

3.1. Global Pharmaceutical Contract Development And Manufacturing Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Pharmaceutical Contract Development And Manufacturing Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Pharmaceutical Contract Development And Manufacturing Market Segmentation

4.1. Global Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Active Pharmaceutical Ingredient (API) Manufacturing

 

Finished Dosage Formulation (FDF) Development & Manufacturing

Secondary Packaging

5. Pharmaceutical Contract Development And Manufacturing Market Regional And Country Analysis

5.1. Global Pharmaceutical Contract Development And Manufacturing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Pharmaceutical Contract Development And Manufacturing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market

6.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Overview

6.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Pharmaceutical Contract Development And Manufacturing Market

7.1. China Pharmaceutical Contract Development And Manufacturing Market Overview

7.2. China Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Pharmaceutical Contract Development And Manufacturing Market

8.1. India Pharmaceutical Contract Development And Manufacturing Market Overview

8.2. India Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Pharmaceutical Contract Development And Manufacturing Market

9.1. Japan Pharmaceutical Contract Development And Manufacturing Market Overview

9.2. Japan Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Pharmaceutical Contract Development And Manufacturing Market

10.1. Australia Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Pharmaceutical Contract Development And Manufacturing Market

11.1. Indonesia Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Pharmaceutical Contract Development And Manufacturing Market

12.1. South Korea Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Pharmaceutical Contract Development And Manufacturing Market

13.1. Western Europe Pharmaceutical Contract Development And Manufacturing Market Overview

13.2. Western Europe Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Pharmaceutical Contract Development And Manufacturing Market

14.1. UK Pharmaceutical Contract Development And Manufacturing Market Overview

14.2. UK Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Pharmaceutical Contract Development And Manufacturing Market

15.1. Germany Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Pharmaceutical Contract Development And Manufacturing Market

16.3. France Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Pharmaceutical Contract Development And Manufacturing Market

17.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Market Overview

17.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Pharmaceutical Contract Development And Manufacturing Market

18.1. Russia Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Pharmaceutical Contract Development And Manufacturing Market

19.1. North America Pharmaceutical Contract Development And Manufacturing Market Overview

19.2. North America Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Pharmaceutical Contract Development And Manufacturing Market

20.1. USA Pharmaceutical Contract Development And Manufacturing Market Overview

20.2. USA Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Pharmaceutical Contract Development And Manufacturing Market

21.1. South America Pharmaceutical Contract Development And Manufacturing Market Overview

21.2. South America Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Pharmaceutical Contract Development And Manufacturing Market

22.1. Brazil Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Pharmaceutical Contract Development And Manufacturing Market

23.1. Middle East Pharmaceutical Contract Development And Manufacturing Market Overview

23.2. Middle East Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Pharmaceutical Contract Development And Manufacturing Market

24.1. Africa Pharmaceutical Contract Development And Manufacturing Market Overview

24.2. Africa Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Pharmaceutical Contract Development And Manufacturing Market Competitive Landscape And Company Profiles

25.1. Pharmaceutical Contract Development And Manufacturing Market Competitive Landscape

25.2. Pharmaceutical Contract Development And Manufacturing Market Company Profiles

25.2.1. Recipharm AB

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Pfizer Inc.

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Catalent Pharma Solutions

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Aenova Group

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Famar

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Market

27. Pharmaceutical Contract Development And Manufacturing Market Trends And Strategies

28. Pharmaceutical Contract Development And Manufacturing Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

 


List of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: China, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: India, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: Japan, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: Australia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: Indonesia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: South Korea, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: Western Europe, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: UK, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: Germany, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: France, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Russia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: North America, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: USA, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: South America, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: Brazil, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: Middle East, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: Africa, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: Recipharm AB Financial Performance

Figure 26: Pfizer Inc. Financial Performance

Figure 27: Catalent Pharma Solutions Financial Performance

Figure 28: Aenova Group Financial Performance

Figure 29: Famar Financial Performance


List of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Pharmaceutical Contract Development And Manufacturing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: China, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: India, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: Japan, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: Australia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: Indonesia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: South Korea, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: Western Europe, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: UK, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: Germany, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: France, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Russia, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: North America, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: USA, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: South America, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: Brazil, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: Middle East, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: Africa, Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: Recipharm AB Financial Performance

Table 26: Pfizer Inc. Financial Performance

Table 27: Catalent Pharma Solutions Financial Performance

Table 28: Aenova Group Financial Performance

Table 29: Famar Financial Performance

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022